Leopard Energy, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Leopard Energy, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $6.0K | Oct 21, 2025 |
| FY2025 | Jul 31, 2024 | $4.4K | Oct 21, 2025 |
| FY2024 | Jul 31, 2023 | $0 | Nov 22, 2024 |
| FY2023 | Jul 31, 2022 | $0 | Apr 17, 2024 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Jul 31, 2012 | $0 | Nov 21, 2012 |
| FY2012 | Jul 31, 2011 | $0 | Nov 21, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $6.0K | Oct 21, 2025 |
| FY2025 | Jul 31, 2024 | $4.4K | Oct 21, 2025 |
| FY2024 | Jul 31, 2023 | $0 | Nov 22, 2024 |
| FY2022 | Jul 31, 2022 | $11 | Oct 6, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $31.8K | Oct 21, 2025 |
| FY2025 | Jul 31, 2024 | ($252.8K) | Oct 21, 2025 |
| FY2024 | Jul 31, 2023 | ($148.9K) | Nov 22, 2024 |
| FY2023 | Jul 31, 2022 | ($1.94M) | Apr 17, 2024 |
| FY2022 | Jul 31, 2021 | ($550.2K) | Oct 6, 2022 |
| FY2021 | Jul 31, 2020 | ($233.1K) | Dec 15, 2021 |
| FY2020 | Jul 31, 2019 | ($14.1K) | Aug 13, 2020 |
| FY2019 | Jul 31, 2018 | ($2.0K) | Oct 29, 2019 |
| FY2018 | Jul 31, 2017 | ($6.9K) | Dec 14, 2018 |
| FY2016 | Jul 31, 2016 | ($95.0K) | Nov 30, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | ($58.9K) | Oct 21, 2025 |
| FY2025 | Jul 31, 2024 | ($282.7K) | Oct 21, 2025 |
| FY2024 | Jul 31, 2023 | ($139.4K) | Nov 22, 2024 |
| FY2023 | Jul 31, 2022 | ($1.91M) | Apr 17, 2024 |
| FY2020 | Jul 31, 2020 | ($233.0K) | Aug 13, 2020 |
| FY2020 | Jul 31, 2019 | ($14.1K) | Aug 13, 2020 |
| FY2019 | Jul 31, 2018 | ($2.0K) | Oct 29, 2019 |
| FY2018 | Jul 31, 2017 | ($6.9K) | Dec 14, 2018 |
| FY2016 | Jul 31, 2016 | ($48.4K) | Nov 30, 2017 |
| FY2016 | Jul 31, 2015 | ($65.3K) | Nov 30, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Jul 31, 2014 | $6.5K | Nov 13, 2015 |
| FY2014 | Jul 31, 2013 | $4.8K | Nov 13, 2014 |
| FY2013 | Jul 31, 2012 | $10.8K | Nov 12, 2013 |
| FY2012 | Jul 31, 2011 | $29.8K | Nov 21, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | ($76.6K) | Oct 21, 2025 |
| FY2025 | Jul 31, 2024 | ($154.3K) | Oct 21, 2025 |
| FY2024 | Jul 31, 2023 | ($48.4K) | Nov 22, 2024 |
| FY2023 | Jul 31, 2022 | ($181.4K) | Apr 17, 2024 |
| FY2022 | Jul 31, 2021 | ($494.5K) | Oct 6, 2022 |
| FY2021 | Jul 31, 2020 | ($10.5K) | Dec 15, 2021 |
| FY2020 | Jul 31, 2019 | ($19.5K) | Aug 13, 2020 |
| FY2019 | Jul 31, 2018 | ($26.4K) | Oct 29, 2019 |
| FY2018 | Jul 31, 2017 | ($26.6K) | Dec 14, 2018 |
| FY2013 | Jul 31, 2013 | ($856.0K) | Nov 12, 2013 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Jul 31, 2021 | $317.3K | Oct 28, 2021 |
| FY2021 | Jul 31, 2020 | $16.2K | Oct 28, 2021 |
| FY2012 | Jul 31, 2012 | $0 | Nov 21, 2012 |
| FY2012 | Jul 31, 2011 | $0 | Nov 21, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $51.4K | Oct 21, 2025 |
| FY2025 | Jul 31, 2024 | $45.7K | Oct 21, 2025 |
| FY2024 | Jul 31, 2023 | $3 | Nov 22, 2024 |
| FY2023 | Jul 31, 2022 | $8.0K | Apr 17, 2024 |
| FY2022 | Jul 31, 2021 | $1.81M | Oct 6, 2022 |
| FY2021 | Jul 31, 2020 | $1.38M | Dec 15, 2021 |
| FY2020 | Jul 31, 2019 | $1.37M | Aug 13, 2020 |
| FY2019 | Jul 31, 2018 | $469 | Oct 29, 2019 |
| FY2018 | Jul 31, 2017 | $0 | Dec 14, 2018 |
| FY2016 | Jul 31, 2015 | $10.0K | Nov 30, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $134.9K | Oct 21, 2025 |
| FY2025 | Jul 31, 2024 | $243.3K | Oct 21, 2025 |
| FY2024 | Jul 31, 2023 | $315.6K | Nov 22, 2024 |
| FY2023 | Jul 31, 2022 | $206.7K | Apr 17, 2024 |
| FY2022 | Jul 31, 2021 | $748.6K | Oct 6, 2022 |
| FY2021 | Jul 31, 2020 | $443.6K | Dec 15, 2021 |
| FY2014 | Jul 31, 2014 | $665.0K | Nov 13, 2014 |
| FY2014 | Jul 31, 2013 | $595.3K | Nov 13, 2014 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | ($83.5K) | Oct 21, 2025 |
| FY2025 | Jul 31, 2024 | ($197.6K) | Oct 21, 2025 |
| FY2025 | Jul 31, 2023 | ($315.6K) | Oct 21, 2025 |
| FY2024 | Jul 31, 2022 | ($198.7K) | Nov 22, 2024 |
| FY2023 | Jul 31, 2021 | $1.04M | Apr 17, 2024 |
| FY2022 | Jul 31, 2020 | $934.1K | Oct 6, 2022 |
| FY2020 | Jul 31, 2019 | $1.17M | Aug 13, 2020 |
| FY2020 | Jul 31, 2018 | ($208.4K) | Aug 13, 2020 |
| FY2019 | Jul 31, 2017 | ($206.4K) | Oct 29, 2019 |
| FY2018 | Jul 31, 2016 | ($199.5K) | Dec 14, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Jul 31, 2023 | $0 | Dec 15, 2023 |
| FY2023 | Jul 31, 2022 | $0 | Dec 15, 2023 |
| FY2022 | Jul 31, 2021 | $964.6K | Oct 6, 2022 |
| FY2021 | Jul 31, 2020 | $964.6K | Dec 15, 2021 |
| FY2020 | Jul 31, 2019 | $964.6K | Aug 13, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | ($11.69M) | Oct 21, 2025 |
| FY2025 | Jul 31, 2024 | ($11.72M) | Oct 21, 2025 |
| FY2024 | Jul 31, 2023 | ($11.47M) | Nov 22, 2024 |
| FY2023 | Jul 31, 2022 | ($11.32M) | Apr 17, 2024 |
| FY2022 | Jul 31, 2021 | ($9.39M) | Oct 6, 2022 |
| FY2021 | Jul 31, 2020 | ($8.86M) | Dec 15, 2021 |
| FY2020 | Jul 31, 2019 | ($8.63M) | Aug 13, 2020 |
| FY2019 | Jul 31, 2018 | ($8.58M) | Oct 29, 2019 |
| FY2018 | Jul 31, 2017 | ($8.58M) | Dec 14, 2018 |
| FY2016 | Jul 31, 2016 | ($8.57M) | Nov 30, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Jul 31, 2023 | $3 | Apr 17, 2024 |
| FY2023 | Jul 31, 2022 | $320 | Apr 17, 2024 |
| FY2022 | Jul 31, 2021 | $70.2K | Oct 6, 2022 |
| FY2022 | Jul 31, 2020 | $115 | Oct 6, 2022 |
| FY2021 | Jul 31, 2019 | $90 | Dec 15, 2021 |
| FY2012 | Jul 31, 2012 | $0 | Nov 21, 2012 |
| FY2013 | Jul 31, 2011 | $7 | Nov 12, 2013 |
| FY2012 | Jul 31, 2010 | $158 | Nov 21, 2012 |
| FY2013 | Jul 31, 2008 | $15.7K | Nov 12, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | 0 | Oct 21, 2025 |
| FY2025 | Jul 31, 2024 | 0 | Oct 21, 2025 |
| FY2024 | Jul 31, 2023 | 0 | Nov 22, 2024 |
| FY2023 | Jul 31, 2022 | (2) | Apr 17, 2024 |
| FY2020 | Jul 31, 2020 | 0 | Aug 13, 2020 |
| FY2020 | Jul 31, 2019 | 0 | Aug 13, 2020 |
| FY2019 | Jul 31, 2018 | 0 | Oct 29, 2019 |
| FY2018 | Jul 31, 2017 | 0 | Dec 14, 2018 |
| FY2016 | Jul 31, 2016 | 0 | Nov 30, 2017 |
| FY2016 | Jul 31, 2015 | 0 | Nov 30, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | 0 | Oct 21, 2025 |
| FY2025 | Jul 31, 2024 | 0 | Oct 21, 2025 |
| FY2024 | Jul 31, 2023 | 0 | Nov 22, 2024 |
| FY2023 | Jul 31, 2022 | (2) | Apr 17, 2024 |
| FY2020 | Jul 31, 2020 | 0 | Aug 13, 2020 |
| FY2020 | Jul 31, 2019 | 0 | Aug 13, 2020 |
| FY2019 | Jul 31, 2018 | 0 | Oct 29, 2019 |
| FY2018 | Jul 31, 2017 | 0 | Dec 14, 2018 |
| FY2016 | Jul 31, 2016 | 0 | Nov 30, 2017 |
| FY2016 | Jul 31, 2015 | 0 | Nov 30, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | 1.27M | Oct 21, 2025 |
| FY2025 | Jul 31, 2024 | 1.27M | Oct 21, 2025 |
| FY2024 | Jul 31, 2023 | 1.27M | Nov 22, 2024 |
| FY2023 | Jul 31, 2022 | 961,448 | Apr 17, 2024 |
| FY2022 | Jul 31, 2021 | 388.99M | Oct 6, 2022 |
| FY2021 | Jul 31, 2020 | 171.79M | Dec 15, 2021 |
| FY2020 | Jul 31, 2019 | 24.32M | Aug 13, 2020 |
| FY2019 | Oct 31, 2018 | 19.52M | Oct 29, 2019 |
| FY2018 | Jul 31, 2018 | 24.32M | Dec 14, 2018 |
| FY2018 | Jul 31, 2017 | 19.52M | Dec 14, 2018 |